Skip to main content

Current Atherosclerosis Reports

Ausgabe 11/2020

Inhalt (8 Artikel)

Zur Zeit gratis COVID-19 Letter to the Editor

Biological Factors Linking ApoE ε4 Variant and Severe COVID-19

Jameel Inal

Nonstatin Drugs (M. Vrablik, Section Editor)

Targeting Inflammation to Reduce Residual Cardiovascular Risk

Oluremi N. Ajala, Brendan M. Everett

Nonstatin Drugs (M. Vrablik, Section Editor)

Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia

Sergei N. Pokrovsky, Olga I. Afanasieva, Marat V. Ezhov

Open Access Nonstatin Drugs (M. Vrablik, Section Editor)

The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia

Peter E. Penson, Maciej Banach

Statin Drugs (R. Ceska, Section Editor)

The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia

Jing Pang, Dick C. Chan, Gerald F. Watts

Statin Drugs (R Ceska, Section Editor)

Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment

Antonio Gallo, Sophie Béliard, Laura D’Erasmo, Eric Bruckert

Women and Ischemic Heart Disease (P. Kohli, Section Editor)

Gender Differences in Residual Risk Factors for Major Adverse Cardiovascular Events Following ACS and How to Bridge the Gap

Olivia Manfrini, Edina Cenko, Raffaele Bugiardini

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.